Accessibility Menu
 

Aptose Biosciences

(OTC) APTOF

Current Price$1.72
Market Cap$4.39M
Since IPO (1992)-100%
5 Year-100%
1 Year-15%
1 Month+2%

Aptose Biosciences Financials at a Glance

Market Cap

$4.39M

Revenue (TTM)

$0.00

Net Income (TTM)

$25.47

EPS (TTM)

$-10.41

P/E Ratio

-0.17

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$1.72

Volume

579

Open

$1.68

Previous Close

$1.72

Daily Range

$1.68 - $1.73

52-Week Range

$0.64 - $2.00

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aptose Biosciences

Industry

Biotechnology

Employees

14

CEO

William G. Rice, PhD

APTOF Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-5.88%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$4.39M

Shares Outstanding

2.55M

Volume

579

Avg. Volume

7.80K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Aptose Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.11

+1.1%

Gross Margin

N/A

N/A

Market Cap

$4.39M

N/A

Market Cap/Employee

$0.27

N/A

Employees

14

N/A

Net Income

$7.76

+4.9%

EBITDA

$7.32

+3.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.10

+0.6%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$27.87

+2.7%

Short Term Debt

$0.19

+0.5%

Return on Assets

-252.92%

+1.1%

Return on Invested Capital

311.03%

+0.8%

Free Cash Flow

$5.64

+0.8%

Operating Cash Flow

$5.64

+0.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7269.08+0.01%
^DJIDJI
$49307.82+0.01%
^IXICNASDAQ
$25350.96+0.01%
BTCBitcoin
$81475.00+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$108.15+0.13%
DGXXDigi Power X
$5.11+0.29%
NOKNokia
$13.42+0.02%
POETPoet Technologies
$9.21+0.30%

Questions About APTOF

What is the current price of Aptose Biosciences?

Aptose Biosciences is trading at $1.72 per share.

What is the 52-week range for Aptose Biosciences?

Over the past 52 weeks, Aptose Biosciences has traded between $0.64 and $2.00.

How much debt does Aptose Biosciences have?

As of the most recent reporting period, Aptose Biosciences reported total debt of $28.07M.

How much cash does Aptose Biosciences have on hand?

Aptose Biosciences reported $4.10M in cash and cash equivalents in its most recent financial results.

What is Aptose Biosciences’s dividend yield?

Aptose Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.